Get startedLog in
    Picture of AprilBio Co logo

    397030 — AprilBio Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for AprilBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-10,220-52,713-8,959-14,13020,005
    Depreciation
    Amortisation
    Non-Cash Items1,35157,511-1,8731,690-812
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital1,179-2,0333,5351,7072,060
    Change in Accounts Receivable
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-7,3293,252-6,704-10,05921,960
    Capital Expenditures-480-706-89.6-512-445
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-6,557-23,094-31,552-6,542-22,352
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-7,037-23,800-31,642-7,054-22,797
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities17,88034,79320,32816,312-2,513
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash3,51514,245-17,093-697-3,240